U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from Gene

Items: 1 to 20 of 58

1.
CYP4F2 is a human-specific determinant of circulating N-acyl amino acid levels
Julia T. Tanzo, Veronica L. Li, Amanda L. Wiggenhorn, Maria Dolores Moya-Garzon, Wei Wei, Xuchao Lyu, Wentao Dong, Usman A. Tahir, Zsu-Zsu Chen, Daniel E. Cruz, Shuliang Deng, Xu Shi, Shuning Zheng, Yan Guo, Mario Sims, Monther Abu-Remaileh, James G. Wilson, Robert E. Gerszten, Jonathan Z. Long, Mark D. Benson
J Biol Chem. 2023 Jun; 299(6): 104764. Published online 2023 Apr 28. doi: 10.1016/j.jbc.2023.104764
PMCID:
PMC10318452
AbstractArticlePDF–2.6M
2.
Computational analysis of missense variant CYP4F2*3 (V433M) in association with human CYP4F2 dysfunction: a functional and structural impact
Mahvash Farajzadeh-Dehkordi, Ladan Mafakher, Fatemeh Samiee-Rad, Babak Rahmani
BMC Mol Cell Biol. 2023; 24: 17. Published online 2023 May 9. doi: 10.1186/s12860-023-00479-0
PMCID:
PMC10170697
AbstractArticlePDF–2.2M
3.
Suggestive evidence of CYP4F2 gene polymorphisms with HAPE susceptibility in the Chinese Han population
Lining Si, Haiyuan Wang, Rong Wang, Lhachen Tsering, Qifu Long, Yahui Jiang, Yun Yi, Yanli Zhao
PLoS One. 2023; 18(1): e0280136. Published online 2023 Jan 12. doi: 10.1371/journal.pone.0280136
PMCID:
PMC9836295
AbstractArticlePDF–1.1M
4.
The correlation between CYP4F2 variants and chronic obstructive pulmonary disease risk in Hainan Han population
Yipeng Ding, Yixiu Yang, Quanni Li, Qiong Feng, Dongchuan Xu, Cibing Wu, Jie Zhao, Xiaoli Zhou, Huan Niu, Ping He, Jianfang Liu, Hongxia Yao
Respir Res. 2020; 21: 86. Published online 2020 Apr 15. doi: 10.1186/s12931-020-01348-6
PMCID:
PMC7161254
AbstractArticlePDF–641K
5.
Genetic variants in CYP4F2 were significantly correlated with susceptibility to ischemic stroke
Yuan Wu, Junjie Zhao, Yonglin Zhao, Tingqin Huang, Xudong Ma, Honggang Pang, Ming Zhang
BMC Med Genet. 2019; 20: 155. Published online 2019 Sep 11. doi: 10.1186/s12881-019-0888-6
PMCID:
PMC6737589
AbstractArticlePDF–710K
6.
Effect of CYP4F2, VKORC1, and CYP2C9 in Influencing Coumarin Dose: A Single-Patient Data Meta-Analysis in More Than 15,000 Individuals
Elisa Danese, Sara Raimondi, Martina Montagnana, Angela Tagetti, Taimour Langaee, Paola Borgiani, Cinzia Ciccacci, Antonio J. Carcas, Alberto M. Borobia, Hoi Y. Tong, Cristina Dávila-Fajardo, Mariana Rodrigues Botton, Stephane Bourgeois, Panos Deloukas, Michael D. Caldwell, Jim K. Burmester, Richard L. Berg, Larisa H. Cavallari, Katarzyna Drozda, Min Huang, Li-Zi Zhao, Han-Jing Cen, Rocio Gonzalez-Conejero, Vanessa Roldan, Yusuke Nakamura, Taisei Mushiroda, Inna Y. Gong, Richard B. Kim, Keita Hirai, Kunihiko Itoh, Carlos Isaza, Leonardo Beltrán, Enrique Jiménez-Varo, Marisa Cañadas-Garre, Alice Giontella, Marianne K. Kringen, Kari Bente Foss Haug, Hye Sun Gwak, Kyung Eun Lee, Pietro Minuz, Ming Ta Michael Lee, Steven A. Lubitz, Stuart Scott, Cristina Mazzaccara, Lucia Sacchetti, Ece Genç, Mahmut Özer, Anil Pathare, Rajagopal Krishnamoorthy, Andras Paldi, Virginie Siguret, Marie-Anne Loriot, Vijay Kumar Kutala, Guilherme Suarez-Kurtz, Jamila Perini, Josh C. Denny, Andrea H. Ramirez, Balraj Mittal, Saurabh Singh Rathore, Hersh Sagreiya, Russ Altman, Mohamed Hossam A. Shahin, Sherief I. Khalifa, Nita A. Limdi, Charles Rivers, Aditi Shendre, Chrisly Dillon, Ivet M. Suriapranata, Hong-Hao Zhou, Sheng-Lan Tan, Vacis Tatarunas, Vaiva Lesauskaite, Yumao Zhang, Anke H. Maitland-van der Zee, Talitha I. Verhoef, Anthonius de Boer, Monica Taljaard, Carlo Federico Zambon, Vittorio Pengo, Jieying Eunice Zhang, Munir Pirmohamed, Julie A. Johnson, Cristiano Fava
Clin Pharmacol Ther. Author manuscript; available in PMC 2020 Jun 1.
Published in final edited form as: Clin Pharmacol Ther. 2019 Jun; 105(6): 1477–1491. Published online 2019 Feb 17. doi: 10.1002/cpt.1323
PMCID:
PMC6542461
AbstractArticlePDF–613K
7.
Cytochrome P450 family 4 subfamily F member 2 (CYP4F2) rs1558139, rs2108622 polymorphisms and susceptibility to several cardiovascular and cerebrovascular diseases
Tao Zhang, Kuiying Yu, Xuhua Li
BMC Cardiovasc Disord. 2018; 18: 29. Published online 2018 Feb 9. doi: 10.1186/s12872-018-0763-y
PMCID:
PMC5807755
AbstractArticlePDF–1.0M
8.
Influence of the CYP4F2 polymorphism on the risk of hemorrhagic complications in coumarin-treated patients
Peng Chen, Ye-Qi Sun, Guo-Ping Yang, Rong Li, Jie Pan, Yu-Sheng Zhou
Saudi Med J. 2016 Apr; 37(4): 361–368. doi: 10.15537/smj.2016.4.14036
PMCID:
PMC4852013
AbstractArticlePDF–769K
9.
PharmGKB summary: very important pharmacogene information for CYP4F2
Maria L. Alvarellos, Katrin Sangkuhl, Roxana Daneshjou, Michelle Whirl-Carrillo, Russ B. Altman, Teri E. Klein
Pharmacogenet Genomics. Author manuscript; available in PMC 2016 Jan 1.
Published in final edited form as: Pharmacogenet Genomics. 2015 Jan; 25(1): 41–47. doi: 10.1097/FPC.0000000000000100
PMCID:
PMC4261059
ArticlePDF–175K
10.
Vascular characterization of mice with endothelial expression of cytochrome P450 4F2
Jennifer Cheng, Matthew L. Edin, Samantha L. Hoopes, Hong Li, J. Alyce Bradbury, Joan P. Graves, Laura M. DeGraff, Fred B. Lih, Victor Garcia, Jafar Sadik B. Shaik, Kenneth B. Tomer, Gordon P. Flake, John R. Falck, Craig R. Lee, Samuel M. Poloyac, Michal L. Schwartzman, Darryl C. Zeldin
FASEB J. 2014 Jul; 28(7): 2915–2931. doi: 10.1096/fj.13-241927
PMCID:
PMC4062824
AbstractArticle
11.
CYP4F2 genetic polymorphisms are associated with coronary heart disease in a Chinese population
Changqing Yu, Qingkai Yan, Chunjiang Fu, Weibin Shi, Hongyong Wang, Chunyu Zeng, Xukai Wang
Lipids Health Dis. 2014; 13: 83. Published online 2014 May 20. doi: 10.1186/1476-511X-13-83
PMCID:
PMC4052825
AbstractArticlePDF–253K
12.
Impact of the CYP4F2 p.V433M Polymorphism on Coumarin Dose Requirement: Systematic Review and Meta-Analysis
E Danese, M Montagnana, JA Johnson, AE Rettie, CF Zambon, SA Lubitz, G Suarez-Kurtz, LH Cavallari, L Zhao, M Huang, Y Nakamura, T Mushiroda, MK Kringen, P Borgiani, C Ciccacci, NT Au, T Langaee, V Siguret, MA Loriot, H Sagreiya, RB Altman, MHA Shahin, SA Scott, SI Khalifa, B Chowbay, IM Suriapranata, M Teichert, BH Stricker, M Taljaard, MR Botton, JE Zhang, M Pirmohamed, X Zhang, JF Carlquist, BD Horne, MTM Lee, V Pengo, GC Guidi, P Minuz, C Fava
Clin Pharmacol Ther. Author manuscript; available in PMC 2013 Dec 1.
Published in final edited form as: Clin Pharmacol Ther. 2012 Dec; 92(6): 746–756. Published online 2012 Nov 7. doi: 10.1038/clpt.2012.184
PMCID:
PMC3731755
AbstractArticlePDF–4.7M
13.
Correlation between single nucleotide polymorphisms in CYP4F2 and warfarin dosing in chinese valve replacement patients
Jie-Hui Li, Guo-Guo Ma, Shu-Qiang Zhu, Hao Yan, Yong-Bing Wu, Jian-Jun Xu
J Cardiothorac Surg. 2012; 7: 97. Published online 2012 Sep 27. doi: 10.1186/1749-8090-7-97
PMCID:
PMC3487995
AbstractArticlePDF–796K
14.
Common Variants of Cytochrome P450 4F2 Exhibit Altered Vitamin E-ω-Hydroxylase Specific Activity
Sabrina A. Bardowell, David E. Stec, Robert S. Parker
J Nutr. 2010 Nov; 140(11): 1901–1906. Published online 2010 Sep 22. doi: 10.3945/jn.110.128579
PMCID:
PMC2955872
AbstractArticlePDF–598K
15.
Factor-Analysis Methods for Higher-Performance Neural Prostheses
Gopal Santhanam, Byron M. Yu, Vikash Gilja, Stephen I. Ryu, Afsheen Afshar, Maneesh Sahani, Krishna V. Shenoy
J Neurophysiol. 2009 Aug; 102(2): 1315–1330. Published online 2009 Mar 18. doi: 10.1152/jn.00097.2009
PMCID:
PMC2724333
AbstractArticle
16.
CYP4F2 Is a Vitamin K1 Oxidase: An Explanation for Altered Warfarin Dose in Carriers of the V433M Variant
Matthew G. McDonald, Mark J. Rieder, Mariko Nakano, Clara K. Hsia, Allan E. Rettie
Mol Pharmacol. 2009 Jun; 75(6): 1337–1346. Published online 2009 Mar 18. doi: 10.1124/mol.109.054833
PMCID:
PMC2684883
AbstractArticlePDF–321K
17.
Association of a Functional Cytochrome P450 4F2 Haplotype with Urinary 20-HETE and Hypertension
Hong Liu, Yanyan Zhao, Dong Nie, Jingpu Shi, Lingyu Fu, Yan Li, Dahai Yu, Jingyu Lu
J Am Soc Nephrol. 2008 Apr; 19(4): 714–721. doi: 10.1681/ASN.2007060713
PMCID:
PMC2390968
AbstractArticle
18.
CYP4F2 genetic variant alters required warfarin dose
Michael D. Caldwell, Tarif Awad, Julie A. Johnson, Brian F. Gage, Mat Falkowski, Paul Gardina, Jason Hubbard, Yaron Turpaz, Taimour Y. Langaee, Charles Eby, Cristi R. King, Amy Brower, John R. Schmelzer, Ingrid Glurich, Humberto J. Vidaillet, Steven H. Yale, Kai Qi Zhang, Richard L. Berg, James K. Burmester
Blood. 2008 Apr 15; 111(8): 4106–4112. Prepublished online 2008 Feb 4. doi: 10.1182/blood-2007-11-122010
PMCID:
PMC2288721
AbstractArticle
19.
A Genome-wide Association Study Discovers 46 Loci of the Human Metabolome in the Hispanic Community Health Study/Study of Latinos
Elena V. Feofanova, Han Chen, Yulin Dai, Peilin Jia, Megan L. Grove, Alanna C. Morrison, Qibin Qi, Martha Daviglus, Jianwen Cai, Kari E. North, Cathy C. Laurie, Robert C. Kaplan, Eric Boerwinkle, Bing Yu
Am J Hum Genet. 2020 Nov 5; 107(5): 849–863. Published online 2020 Oct 7. doi: 10.1016/j.ajhg.2020.09.003
PMCID:
PMC7675000
AbstractArticlePDF–1.8M
20.
CYP4F2 and VKORC1 Polymorphisms Amplify the Risk of Carotid Plaque Formation
Stefan Cristian Vesa, Sonia Irina Vlaicu, Vitalie Vacaras, Sorin Crisan, Octavia Sabin, Sergiu Pasca, Adrian Pavel Trifa, Tamas Rusz-Fogarasi, Madalina Sava, Anca Dana Buzoianu
Genes (Basel) 2020 Jul; 11(7): 822. Published online 2020 Jul 20. doi: 10.3390/genes11070822
PMCID:
PMC7396977
AbstractArticlePDF–671K

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center